ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 172 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2015. The put-call ratio across all filers is 1.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $14,653 | -72.8% | 411 | -64.8% | 0.00% | -80.0% |
Q2 2023 | $53,834 | +0.9% | 1,167 | -12.3% | 0.01% | -16.7% |
Q1 2023 | $53,333 | +24.6% | 1,330 | +43.9% | 0.01% | +20.0% |
Q4 2022 | $42,809 | +137.8% | 924 | +111.4% | 0.01% | +150.0% |
Q3 2022 | $18,000 | +80.0% | 437 | +155.6% | 0.00% | +100.0% |
Q2 2022 | $10,000 | +900.0% | 171 | +677.3% | 0.00% | – |
Q1 2022 | $1,000 | -80.0% | 22 | -62.7% | 0.00% | -100.0% |
Q4 2021 | $5,000 | +150.0% | 59 | +136.0% | 0.00% | – |
Q3 2021 | $2,000 | – | 25 | +733.3% | 0.00% | – |
Q2 2021 | $0 | -100.0% | 3 | -94.7% | 0.00% | -100.0% |
Q1 2021 | $6,000 | – | 57 | +1325.0% | 0.00% | – |
Q1 2020 | $0 | -100.0% | 4 | -97.1% | 0.00% | -100.0% |
Q3 2019 | $5,000 | 0.0% | 136 | +44.7% | 0.00% | -66.7% |
Q1 2016 | $5,000 | -16.7% | 94 | +70.9% | 0.00% | -25.0% |
Q4 2015 | $6,000 | – | 55 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iguana Healthcare Management, LLC | 75,000 | $5,084,000 | 2.52% |
COLUMBIA WANGER ASSET MANAGEMENT LLC | 1,237,825 | $83,900,000 | 1.18% |
CAPITAL INTERNATIONAL LTD /CA/ | 206,718 | $14,011,000 | 0.91% |
Cormorant Asset Management, LP | 75,000 | $5,084,000 | 0.74% |
Capital International Sarl | 107,450 | $7,283,000 | 0.63% |
Rock Springs Capital Management LP | 159,750 | $10,828,000 | 0.62% |
Opus Point Partners Management, LLC | 12,201 | $827,000 | 0.61% |
Hood River Capital Management LLC | 109,629 | $7,431,000 | 0.56% |
Aureus Asset Management, LLC | 50,740 | $2,927,000 | 0.51% |
ROCKEFELLER FINANCIAL SERVICES INC | 374,663 | $25,395,000 | 0.51% |